News
Feb 07, 2026
Harvard Medical School’s (HMS) UDN and Countway Library of Medicine are very excited to invite you to our 2026 February Rare Disease Month Programming. For the most…
Feb 06, 2026
A rare and potentially fatal form of heart disease known as transthyretin amyloid cardiomyopathy, or ATTR-CM, is increasingly drawing clinical attention as…
Feb 06, 2026
Amyloidosis occurs when abnormal, misfolded proteins deposit in different parts of the body, including the carpal tunnel in the wrist. It often builds up in the…
Feb 06, 2026
NEW YORK—In 2002, Don Brockman was diagnosed with amyloidosis. The following year, he and his wife launched the nonprofit Amyloidosis Foundation, and in 2007,…
Feb 05, 2026
The success rate of left atrial appendage closure to prevent stroke was high and the rate of complications was low in patients with cardiac amyloidosis, according…
Feb 04, 2026
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be…
Feb 04, 2026
TUESDAY, Feb. 3, 2026 -- In guidelines issued by the American Society of Hematology and published online Jan. 27 in Blood Advances, recommendations are presented…
Feb 04, 2026
To everyone touched by transthyretin (ATTR) amyloidosis; through diagnosis, genetics, or love, come sit with me for a moment.My father's ATTR diagnosisSo, there we…
Feb 04, 2026
Raising Youth Voices is a global collaboration between the National Organization for Rare Disorders (NORD), EURORDIS-Rare Diseases Europe, and Rare Diseases…
Feb 03, 2026
Isabelle LousadaFounder & CEOAmyloidosis Research Consortium Transthyretin amyloid cardiomyopathy (ATTR-CM), including both wild-type (ATTRwt) and…